Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.

AusPAR: Ixekizumab

Australian Public Assessment Report

AusPAR

AusPAR: Ixekizumab [PDF, 1.52 MB]

AusPAR: Ixekizumab [Word, 2.29 MB]

Attachment: Product Information: Ixekizumab [PDF, 405.37 KB]

Attachment: Product Information: Ixekizumab [Word, 413.65 KB]

Attachment: Extract from Clinical Evaluation Report: Ixekizumab [PDF, 4.35 MB]

Attachment: Extract from Clinical Evaluation Report: Ixekizumab [Word, 7.71 MB]

Device/Product Name

Taltz

Active ingredients

Ixekizumab

AusPAR Date

8 May 2017

Published

23 May 2017

Submission Number

PM-2015-01878-1-4

Submission Type

New chemical entity

Decision

Approved